Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00602602
Title Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pennsylvania
Indications

pancreatic adenocarcinoma

Therapies

Bevacizumab + Fluorouracil + Oxaliplatin

Bevacizumab + Gemcitabine + Oxaliplatin

Bevacizumab + Gemcitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.